Key Events This Week
27 Jul: Stock opens week at Rs.24.74, gaining 3.91%
29 Jul: New 52-week high at Rs.28.76
30 Jul: Further 52-week high at Rs.29.5
31 Jul: Valuation metrics improve; stock closes at Rs.26.01
27 July 2026: Week Begins with Solid Gains
Unjha Formulations Ltd started the week on a positive note, closing at Rs.24.74, up 3.91% from the previous close. This outpaced the Sensex’s 1.05% gain to 36,207.16 points. The volume was modest at 911 shares, indicating measured investor interest. The stock’s early strength set the tone for the week, reflecting initial optimism amid a broadly positive market environment.
29 July 2026: Breakout to New 52-Week High of Rs.28.76
The stock surged dramatically on 29 July, hitting a new 52-week high of Rs.28.76 during intraday trading, closing at Rs.27.50, a 10.93% increase on the day. This represented a substantial rally, with the stock outperforming the Sensex’s 1.02% gain to 36,524.95 points by a wide margin. Volume spiked to 14,668 shares, signalling heightened trading activity and investor enthusiasm.
This breakout was supported by the stock trading above all key moving averages (5-day through 200-day), indicating strong technical momentum. The stock’s 16.01% intraday gain to the new high underscored robust buying interest. Sector-wide strength in Pharmaceuticals & Biotechnology, with indices also reaching new highs, provided a favourable backdrop for this rally.
Our latest monthly pick, this Large Cap from Aluminium & Aluminium Products, is outperforming the market! See the analysis that helped our Investment Committee select this winner.
- - Market-beating performance
- - Committee-backed winner
- - Aluminium & Aluminium Products standout
30 July 2026: Momentum Continues with Another 52-Week High at Rs.29.5
Unjha Formulations Ltd extended its rally on 30 July, reaching a fresh 52-week high of Rs.29.5. The stock closed at Rs.28.10, up 2.18% on the day, with a strong intraday presence at the new high level. Despite the Sensex trading slightly lower by 0.11% to 36,541.96 points, the stock’s gains highlighted its relative strength within the sector.
Technical indicators remained largely bullish, with the stock trading above all major moving averages. Weekly MACD and Bollinger Bands suggested sustained positive momentum, although some caution was warranted given mildly bearish monthly MACD and weekly RSI signals. The stock’s four-day consecutive gains amounted to a cumulative 23.9% return, significantly outperforming sector peers.
31 July 2026: Valuation Shift Signals Renewed Price Attractiveness
On the final trading day of the week, Unjha Formulations Ltd closed at Rs.26.01, down 7.44% from the previous day’s close but still maintaining a strong weekly gain. The stock’s volume moderated to 4,723 shares. Notably, valuation metrics improved, with the price-to-earnings ratio at 17.73 and EV/EBITDA at 10.74, positioning the stock attractively relative to pharmaceutical peers such as Hester Biosciences and NGL Fine Chem, which trade at significantly higher multiples.
Operational returns remained robust, with a return on capital employed of 40.00% and return on equity of 18.49%, supporting the valuation recalibration. Despite the positive fundamentals, the Mojo Score stood at 34.0 with a Sell grade, reflecting cautious market sentiment amid the stock’s micro-cap status and sector volatility.
Why settle for Unjha Formulations Ltd? SwitchER evaluates this micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Daily Price Performance vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-07-27 | Rs.24.74 | +3.91% | 36,207.16 | +1.05% |
| 2026-07-28 | Rs.24.79 | +0.20% | 36,155.32 | -0.14% |
| 2026-07-29 | Rs.27.50 | +10.93% | 36,524.95 | +1.02% |
| 2026-07-30 | Rs.28.10 | +2.18% | 36,541.96 | +0.05% |
| 2026-07-31 | Rs.26.01 | -7.44% | 36,684.83 | +0.39% |
Key Takeaways
Strong Price Momentum: The stock’s 9.24% weekly gain notably outperformed the Sensex’s 2.39%, driven by two consecutive days of new 52-week highs and sustained buying interest.
Technical Strength: Trading above all major moving averages and supported by bullish weekly MACD and Bollinger Bands, the stock demonstrated robust short-term momentum despite some mixed monthly indicators.
Valuation Appeal: Improved valuation metrics, including a P/E of 17.73 and EV/EBITDA of 10.74, position Unjha Formulations attractively against more expensive sector peers, supported by strong operational returns.
Cautionary Signals: The Mojo Grade remains at Sell, reflecting ongoing risks associated with the company’s micro-cap status and sector volatility. The stock’s sharp decline on 31 July also suggests potential short-term profit-taking or volatility.
Conclusion
Unjha Formulations Ltd’s week was marked by impressive price gains and technical breakthroughs, culminating in new 52-week highs and a favourable valuation shift. The stock’s outperformance relative to the Sensex and its pharmaceutical peers highlights its resilience and growing market appeal. However, the modest Mojo Grade and recent price volatility advise a measured approach. Overall, the week’s developments reflect a stock in strong upward momentum, supported by solid fundamentals and improving market sentiment within a challenging sector environment.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
